Lehrstuhl für Haut- und Geschlechtskrankheiten

Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status (2025) Placke JM, Rajcsanyi LS, Herbst R, Terheyden P, Utikal J, Pföhler C, Kreuter A, et al. Journal article Zinc deficiency-associated dermatitis in a prematurely born infant (2025) Grötsch J, Sticherling M Journal article A Network Biology-Guided Investigation of the Long Noncoding RNAs’ Role in Glaucoma (2025) Choudhari JK, Vera J, Chatterjee T Book chapter / Article in edited volumes A Practical Guideline for MicroRNA Sequencing Data Analysis in Chronic Lymphocytic Leukemia (2025) Suomela T, Zhang L, Vera J, Bruns H, Lai X Book chapter / Article in edited volumes A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article Impact of the digital health application ViViRA on spinal mobility, physical function, quality of life and pain perception in spondyloarthritides patients: a randomized controlled trial (2024) Palm von Alten Blaskowitz PA, Liphardt AM, Bouzas C, Coppers B, Petit P, Vuillerme N, Bundle V, et al. Journal article Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care (2024) Heinlein L, Maron RC, Hekler A, Haggenmüller S, Wies C, Utikal JS, Meier F, et al. Journal article Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood (2024) Liang C, Spörl S, Xiao Y, Habenicht KM, Haeusl SS, Sandner I, Winkler J, et al. Journal article Analysis of the German Compassionate Use Program on spesolimab in patients with generalized pustular psoriasis: evidence outside of clinical trials (2024) Krefting F, Welzel J, Thamm J, Thölken K, Wohlrab J, Müller VL, Kreuter A, et al. Journal article